68Ga-PSMA-11 PET imaging in patients with ongoing androgen deprivation therapy for advanced prostate cancer.
Saskia FassbindDaniela A FerraroJean-Jacques StelmesChristian D FankhauserMatthias GuckenbergerPhilipp A KaufmannDaniel EberliIrene Andrea BurgerBenedikt KranzbühlerPublished in: Annals of nuclear medicine (2021)
In this study, we observed an overall very high detection rate of 94% using PSMA PET imaging in patients with advanced PCa and ongoing ADT. Even in a majority of patients with very low PSA values < 1 ng/ml PSMA-positive lesions were found.